Viewing Study NCT03348904


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-05-23 @ 12:49 PM
Study NCT ID: NCT03348904
Status: TERMINATED
Last Update Posted: 2019-06-13
First Post: 2017-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Sponsor: Incyte Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None programmed cell death protein 1 (PD-1) antibody View
None indoleamine 2,3-dioxygenase (IDO) inhibitor View